Use of ultrarapid acting insulin

Details Use of ultrarapid acting insulin Use of ultrarapid acting insulin

A - Human Necessities

61

K

A61K 38/28 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2733593

Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.

L'invention concerne des méthodes améliorées permettant de traiter hyperglycémie avec une insuline à action ultrarapide combinée à l'insuline glargine, lesquelles méthodes consistent en l'administration prandiale de l'insuline à action ultrarapide, et l'administration d'une première dose d'insuline glargine dans un intervalle d'action de 6 heures par jour.

Affiliated with

Also associated with

Rating

Use of ultrarapid acting insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of ultrarapid acting insulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ultrarapid acting insulin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1766349